Development of rhabdomyolysis after rapid opioid detoxification with subcutaneous naltrexone maintenance therapy.
Chanmugam
A S
AS
Department of Emergency Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. achanmug@jhmi.edu
Hengeller
M
M
Ezenkwele
U
U
D000293:Adolescent; D006471:Gastrointestinal Hemorrhage / Q000209:etiology; D006556:Heroin Dependence / Q000628:therapy*; D006801:Humans; D008658:Inactivation, Metabolic; D008297:Male; D008309:Mallory-Weiss Syndrome / Q000209:etiology; D009271:Naltrexone / Q000493:pharmacokinetics*; D009292:Narcotic Antagonists / Q000493:pharmacokinetics*; D012206:Rhabdomyolysis / Q000209:etiology*; D012769:Shock / Q000209:etiology; D013997:Time Factors; D014839:Vomiting / Q000150:complications
D009292:Narcotic Antagonists; D009271:Naltrexone